Global Veterinary Infectious Diseases Diagnostics Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Technology Type (Immunodiagnostics, Molecular Diagnostics, Hematology, Urinalysis, Others), By Pathogen Type (Virus, Bacteria, Parasite), By Animal Type (Companion Animal (Cats, Dogs, Horse, Others), Livestock (Cattle, Swine, Sheep, Others)), By End-User (Diagnostics Laboratories, Veterinary Clinics, Research Centers), And By Geography - Forecasts From 2022 To 2027

The veterinary infectious diseases diagnostics market is estimated to grow at a CAGR of 8.86% to reach a market size of US$4.286 billion in 2027 from US$2.472 billion in 2020.  

The prevalence of diseases such as colony collapse disorder, zoonotic diseases, rabies, and canine distemper (which is also called Hardpad disease), among some other diseases, is increasing due to the different types of bacteria, viruses, and parasites present in the surroundings and the lack of practice of proper hygiene among the animals. This leads to spreading infections and causes health-related problems for pets and livestock owners. Thus, this is encouraging them to go for regular veterinary infectious disease diagnostics checkups to keep the animal health in check and prevent them from contracting a disease, which is boosting the market growth.

Technology Launched by Major Market Players

The better, advanced, and diverse varieties of veterinary infectious disease diagnostics with enhanced features can effectively aid in the proper and efficient diagnosis and detection of diseases. These products are being launched, and products being offered by existing and new players in different markets are estimated to lead to increased adoption and propel the market growth further over the forecast period.

Some of the examples of the technology launches and animal types are as follows:

•  Zoetis, one of the leading companies dealing in the provision of animal health services ad diagnostics, announced that they had launched a new technology to expand their technology and services under their portfolio by releasing a technology called the “Stablelab.” It is a handheld device, a type of point-of-care diagnostic blood test that can provide veterinarians with critical information about equine inflammation within 10 minutes. The hand-held reader detects and quantifies the biomarker Serum Amyloid A (SAA), which is one of the major acute-phase proteins produced by the liver, and its early detection and diagnosis can help the veterinarians detect infectious diseases sooner and respond to the inflammation caused in the caused by the infection earlier even before the symptoms start.
• Zoetis announced that they had signed an agreement with Colorado State University (CSU) to facilitate the establishment of a research lab at CSU. In this lab, the livestock immune system and the target were tested to target new immunotherapies, which paved the way for other new and better alternatives to the antibiotics used in the food-producing animals. In addition, this Incubator Research Lab will operate at the Research Innovation Center on the foothills of CSU Campus starting in early 2020. Therefore, due to getting access to the ore laboratories, highly skilled scientists will give Zoetis the ability to better understand the immune system of the livestock to generate new candidates for accelerating the research and development activities further.
• Prosolit, one of the leading companies that are involved in the provision of diagnostic products and technologies for veterinary infectious disease testing, offers a technology called the “ELISA kit for serodiagnosis of Bovine Adenovirus3 “, which is a test designed for the diagnosis of this virus in the cattle. It is an indirect test for blood sera, plasma, and milk. It helps in faster, more effective, and more accurate testing and result declaration as it uses reliable technology and provides many testing kits.

Molecular Diagnostics are estimated to increase their market share over the forecast period as the demand for faster and more effective results and the growing adoption among research centres and diagnostic laboratories.

Molecular diagnostics are a type of diagnostic test that is referred to as the detection of the genomic variants that facilitates the detection, diagnosis, sub-classification, and prognosis. It also includes monitoring the responses to therapy. Molecular diagnostics also include laboratory medicine. The technology used in genomics is increasingly essential for the provision of accurate diagnosis. Molecular diagnostics are estimated to increase their market share over the forecast period, which is attributable to the fact that infectious diseases are getting more complex and are growing increasingly common among livestock and companion animals, thus leading to rising concern among the owners. This encourages them to opt for better and more effective tests that can deliver efficient results in a short period.

Livestock animals to increase their share over the forecast period

Livestock animals are one of the key drivers for sustainable development in agriculture apart from contributing to food security, nutrition, and the alleviation of poverty and economic growth. Out of every five farm animals, about one animal is lost to serious infectious diseases, which can lead to it affecting the individuals in the population globally as they depend on a daily supply of meat, poultry, milk, and other dairy products, the quality of which can deteriorate due to disease. In addition, the cost of the burden of diseases is increasing and can lead to losses of around US$80 billion.

The livestock animals are estimated to hold a notable share over the forecast period since there has been an increase in the number of farm animals suffering from different diseases as mostly the conditions, they are held in are unhygienic and not clean. This results in the growth of bacteria and parasites in water bodies and water bowls they drink, resulting in their feed getting ridden with parasites.  This is driving the requirement of diagnostics and veterinary services for these animals to prevent the risk of getting seriously ill by infections.

Recent Developments

• The Molecular Veterinary Diagnostic Laboratory (MVDL), supported by Australian Aid, was originally inaugurated in Timor-Leste in June 2022 by the Minister of Agriculture and Fisheries (MoAF), Pedro dos Reis, and the Australian Ambassador to Timor-Leste, Bill Costello.
• New Technologies in Veterinary Microbiology Diagnostics, a lifetime learning program, was introduced by ENOVAT in March 2022.
• In 2022, VetZ GmbH was fully acquired by Heska Corporation, a major international supplier of cutting-edge veterinary diagnostic and speciality products and solutions.
• The Svanova product portfolio from Boehringer Ingelheim was purchased by INDICAL BIOSCIENCE GmbH in April 2021, enabling INDICAL to expand its portfolio by 25 assays for cattle.
• Heska Corporation bought Lacuna Diagnostics in January 2021, expanding the company's range of telemedicine services and point-of-care digital cytology technology.
• Productos Quimicos Magiar, a distributor of NEOGEN's food safety diagnostics that address animal health in the food market, was purchased by NEOGEN Corporation in January 2020. The business is intending to expand into the Latin American market with this move.

COVID-19 Impact on Veterinary Infectious Diseases Diagnostics Market

As the majority of nations and their states view pet care and animal care as vital services, the COVID-19 pandemic had a moderate impact on the market for veterinary infectious disease diagnostics. As a result, the pandemic had little effect on growth, since veterinarian practices were often seen as necessary industries. For instance, AmerisourceBergen Corporation 2020 claimed that several veterinarian services have demonstrated substantial improvement since December 2020, such as senior wellness bloodwork (+24%), wellness check (+14%), and heartworm testing (+5%). A rise in pet adoption has also been observed as a result of the pandemic. For instance, the Insurance Research Council reported in its October 2020 report that during the COVID-19 epidemic, over one-third (30%) of Americans adopted a pet. The uptake and demand for veterinary infectious disease diagnoses are anticipated to rise quickly as a result of the rise in pet adoption.

Global Veterinary Infectious Diseases Diagnostics Market Scope:

Report Metric	Details
Market Size Value in 2020	US$2.472 billion
Market Size Value in 2027	US$4.286 billion
Growth Rate	CAGR of 8.86% from 2020 to 2027
Base Year	2020
Forecast Period	2022–2027
Forecast Unit (Value)	USD Billion
Segments Covered	Technology Type, Pathogen Type, Animal Type, End-User, And Geography
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered	IDEXX Laboratories Inc., Zoetis Services LLC, Heska Corporation, MEGACOR Diagnostik GmbH, Demeditec Diagnostics GmbH, DRG INSTRUMENTS GMBH, Chembio Diagnostic Systems, Inc., Virbac, Thermo Fisher Scientific, Inc., BioMerieux, Inc.
Customization Scope	Free report customization with purchase

 

Segmentation:

• By Technology Type
  • Immunodiagnostics
  • Molecular Diagnostics
  • Hematology
  • Urinalysis
  • Others
• By Pathogen Type
  • Virus
  • Bacteria
  • Parasite
• By Animal Type
  • Companion Animal
    • Cats
    • Dogs
    • Horse
    • Others
  • Livestock
    • Cattle
    • Swine
    • Sheep
    • Others
• By End-User
  • Diagnostics Laboratories
  • Veterinary Clinics
  • Research Centers
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Others

---

Frequently Asked Questions (FAQs)

Q1. What is the size of the global veterinary infectious diseases diagnostics market?
A1. Veterinary Infectious Diseases Diagnostics Market was valued at US$2.472 billion in the year 2020. 

Q2. What will be the veterinary infectious diseases diagnostics market size by 2027?
A2. The veterinary infectious diseases diagnostics market is estimated to reach a market size of US$4.286 billion by 2027. 

Q3. What are the growth prospects for the veterinary infectious diseases diagnostics market?
A3. The global veterinary infectious diseases diagnostics market is estimated to grow at a CAGR of 8.86% over the forecast period. 

Q4. How is the global veterinary infectious diseases diagnostics market segmented?
A4. The veterinary infectious diseases diagnostics market has been segmented by technology type, pathogen type, animal type, end-user, and geography.

Q5. What is the base year considered in the veterinary infectious diseases diagnostics market report?
A5. 2020 has been taken as the base year in the global veterinary infectious diseases diagnostics market.